Serum anti-β2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients

This publication has 27 references indexed in Scilit:

• Antibodies to Phospholipid-Binding Plasma Proteins and Occurrence of Thrombosis in Patients with Systemic Lupus Erythematosus
  Clinical Immunology and Immunopathology, 1996
• Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndrome
  Blood Coagulation & Fibrinolysis, 1996
• Antiphospholipid antibodies and thrombosis: assessment of the potential risk for thrombosis
  Lupus, 1996
• The presence of antiphospholipid antibodies in acute myocardial infarction
  Lupus, 1995
• Recurrent stroke and thrombo‐occlusive events in the antiphospholipid syndrome
  Annals of Neurology, 1995
• Exposure of Anionic Phospholipids upon Platelet Activation Permits Binding of β2 Glycoprotein I and Through it that ofIgG Antiphospholipid Antibodies. Studies in Platelets from Patients with Antiphospholipid Syndrome and Normal Subjects
  Journal of Autoimmunity, 1994
• Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease
  The Lancet, 1990
• Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor
  The Lancet, 1990
• Antiphospholipid Antibodies and the Antiphospholipid Syndrome in Systemic Lupus Erythematosus A Prospective Analysis of 500 Consecutive Patients
  Medicine, 1989
• The 1982 revised criteria for the classification of systemic lupus erythematosus
  Arthritis & Rheumatism, 1982